Clinical Trials for Prestige BioPharma

Explore 3 clinical trials worldwide

Showing 1-3 of 3 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Prestige BioPharma

Clinical Trials (3)

NCT05141149
First in Human Phase1/2a Clinical Trial of Anti-PAUF Monoclonal Antibody PBP1510 in Patients With Pancreatic Cancer
PHASE1/PHASE2Recruiting
80 participants
Started: Jun 5, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor4 locations
NCT05108259
To Compare the Pharmacokinetics and Safety of PBP1502 and Humira in Healthy Subjects
PHASE1Recruiting
324 participants
Started: Mar 30, 2022 · Completed: May 31, 2026
1 condition1 sponsor1 location
NCT03390686
A Trial to Compare the Efficacy, Safety, Pharmacokinetics and Immunogenicity of HD204 to Avastin® in Advanced Non-squamous Non-small Cell Lung Cancer Patients
PHASE3Active, not recruiting
650 participants
Started: Nov 15, 2019 · Completed: Dec 31, 2025
2 conditions1 sponsor18 locations